With increasing legislation legalizing marijuana both in Canada and the United States, companies involved in the development of cannabis for medical and other purposes are gaining attention.
But weed stocks, as they are often referred to, have been taking a beating lately, with data showing that many of the stock dumps are sales by executives of major cannabis companies. Is this profit taking, or a reaction to AG Jeff Sessions, who has been an outspoken opponent of legalized marijuana, implying that he might consider a rollback to restore marijuana laws under federal jurisdiction? Its anybodys guess. But rather than rush to unload a company before it goes up in smoke (see what I did there) its worth taking a look at additional assets that a cannabis company may hold.
Top 5 Medical Stocks To Invest In Right Now: American Assets Trust, Inc.(AAT)
- [By Markus Aarnio]
Owens Realty Mortgage’s competitors include American Assets Trust (AAT), Alexandria Real Estate Equities (ARE) and Boston Properties (BXP). American Assets Trust has seen five insider buy transactions and four insider sell transactions this year. American Assets Trust has a dividend yield of 2.78%. Alexandria Real Estate Equities has seen 14 insider sell transactions this year. Alexandria Real Estate Equities has a dividend yield of 4.10%. Boston Properties has seen one insider buy transaction and four insider sell transactions this year. Boston Properties has a dividend yield of 2.43%.
Top 5 Medical Stocks To Invest In Right Now: Old Second Bancorp Inc.(OSBC)
- [By Lisa Levin]
Friday afternoon, the financial sector proved to be a source of strength for the market. Leading the sector was strength from Wins Finance Holdings Inc (NASDAQ: WINS) and Old Second Bancorp Inc. (NASDAQ: OSBC).
Top 5 Medical Stocks To Invest In Right Now: Spark Therapeutics, Inc.(ONCE)
- [By Chris Lange]
Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:
- [By Jim Robertson]
On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):
Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.
- [By Lisa Levin]
Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.
Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.
- [By Paul Ausick]
Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.
Top 5 Medical Stocks To Invest In Right Now: Graco Inc.(GGG)
- [By Lisa Levin]
In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.
- [By Joel Elconin]
At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.
Top 5 Medical Stocks To Invest In Right Now: Inphi Corporation(IPHI)
- [By Lisa Levin]
Technology shares rose by 1.9 percent in the US market on Friday. Top gainers in the sector included Fabrinet (NYSE: FN), and Inphi Corporation (NYSE: IPHI).
- [By Roberto Pedone]
Inphi (IPHI) provides high-speed analog and mixed signal semiconductor solutions for the communications, datacenter and computing markets. This stock closed up 4.7% at $13.25 in Monday’s trading session.
Monday’s Volume: 838,000
Three-Month Average Volume: 202,080
Volume % Change: 378%
From a technical perspective, IPHI jumped higher here right above some near-term support at $12.44 with heavy upside volume. This stock has been uptrending strong for the last five months, with shares soaring higher from its low of $8.62 to its intraday high of $13.85. During that uptrend, shares of IPHI have been consistently making higher lows and higher highs, which is bullish technical price action. That move briefly pushed shares of IPHI into breakout territory, since the stock flirted with some near-term overhead resistance at $13.50.
Traders should now look for long-biased trades in IPHI as long as it’s trending above some near-term support at $12.44 and then once it sustains a move or close above its new 52-week high at $13.85 with volume that hits near or above 202,080 shares. If we get that move soon, then IPHI will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are its next major overhead resistance levels at $14.79 to $16.94, or possibly even $18.